HNRNPA1 and neoplasm: Importantly, hnRNPA1 performed better diagnostically at (a) identifying KRASG12D PDAC and (b) distinguishing between LN-positive and -negative disease, compared with classic tumor biomarkers carcinoembryonic antigen CEA0 and carbohydrate antigens CA19-9 and CA72-4.